Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular kinetics in rectal cancer

N H Terry1, M L Meistrich, L D Roubein

  • 1Department of Experimental Radiotherapy, University of Texas MD Anderson Cancer Center, Houston 77030, USA.

British Journal of Cancer
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay.

ESMO open·2025
Same author

Spermatogonial asynchrony in Tex14 mutant mice lacking intercellular bridges.

Reproduction (Cambridge, England)·2020
Same author

Effect of hormone modulations on donor-derived spermatogenesis or colonization after syngeneic and xenotransplantation in mice.

Andrology·2018
Same author

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Leydig cells contribute to the inhibition of spermatogonial differentiation after irradiation of the rat.

Andrology·2016
Same author

Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

Clinical genetics·2015

Dynamic tumor cell kinetic parameters, like potential doubling time (Tpot), show promise for predicting radiotherapy outcomes in rectal cancers. Understanding these parameters, including labeling index (LI) and S-phase duration (TS), is crucial for personalized treatment selection.

Area of Science:

  • Oncology
  • Radiotherapy
  • Biomedical Engineering

Background:

  • Dynamic tumor cell kinetic parameters, such as potential doubling time (Tpot), are being investigated as predictive biomarkers for radiotherapy outcomes.
  • Rectal cancers exhibit a wide range of kinetic and DNA content parameters that influence treatment response.

Purpose of the Study:

  • To detail the distributions of Tpot and other kinetic parameters (LI, TS) and DNA content (ploidy, SPF) in rectal cancers.
  • To establish baseline data for these parameters to assess their utility in individual treatment selection and outcome prediction.

Main Methods:

  • Biopsies from 119 rectal cancer patients were analyzed using bivariate DNA/bromodeoxyuridine (BrdUrd) flow cytometry.
  • Kinetic parameters including labeling index (LI), S-phase duration (TS), and Tpot were measured.

Related Experiment Videos

  • Tumor DNA ploidy (DNA index) and S-phase fractions (SPFs) were estimated from DNA histograms.

    • Main Results:

    • Of 101 evaluable tumors, 73 were DNA aneuploid. Median Tpot for aneuploid tumors was 3.3 days.
    • Significant correlations were observed between labeling index (LI) and S-phase fraction (SPF) (P < 0.001, r=0.76).
    • Wide distributions were found for LI (quartiles 13.5%, 26.9%) and Tpot (quartiles 2.4, 5.6 days).

    Conclusions:

    • The study provides essential baseline data on kinetic and DNA content parameters in rectal cancers.
    • The wide variability in LI and Tpot underscores their potential importance for personalized radiotherapy.
    • Further research is needed to validate these parameters as predictive biomarkers for treatment outcomes.